Literature DB >> 27202223

Economic Burden of Chemotherapy Related Toxicities in Third Line Metastatic Breast Cancer Patients.

U Majethia1, G Tremblay1, Y P He1, C Faria1, S Mccutcheon2, L Kopenhafer3, A Forsythe1.   

Abstract

Entities:  

Year:  2014        PMID: 27202223     DOI: 10.1016/j.jval.2014.08.2242

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

1.  Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea.

Authors:  Gabriel Tremblay; Unnati Majethia; Janis L Breeze; Ilias Kontoudis; Jeongae Park
Journal:  Clinicoecon Outcomes Res       Date:  2016-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.